Clinical Trials Browser

Phase 1/2 × methyl 5-aminolevulinate × Clear all

NCT02367547 2019-03-28

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Phase 1/2 Unknown

Carcinoma, Basal Cell, Neoplasms, Basal Cell

NCT02149342 2016-07-11

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Phase 1/2 Completed

14 enrolled 8 charts

Keratosis, Actinic